Cargando…

Molecular Classification, Treatment, and Genetic Biomarkers in Triple-Negative Breast Cancer: A Review

Breast cancer is the most common malignancy and the second most common cause of cancer-related mortality in women. Triple-negative breast cancers do not express estrogen receptors, progesterone receptors, or human epidermal growth factor receptor 2 and have a higher recurrence rate, greater metastat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Boya, Natarajan, Elango, Balaji Raghavendran, Hanumantha Rao, Markandan, Uma Devi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829998/ https://www.ncbi.nlm.nih.gov/pubmed/36601658 http://dx.doi.org/10.1177/15330338221145246

Ejemplares similares

Effect of Chitosan Nanoparticle-Loaded Thymus serpyllum on Hydrogen Peroxide-Induced Bone Marrow Stromal Cell Damage
por: Baig, Salma, et al.
Publicado: (2019)

Molecular Classification of Triple-Negative Breast Cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2016)

Editorial: Personalized medicine—Where do we stand regarding bench to bedside translation?
por: Raghavendran, Hanumantha Rao Balaji, et al.
Publicado: (2023)

LncRNA-Based Classification of Triple Negative Breast Cancer Revealed Inherent Tumor Heterogeneity and Vulnerabilities
por: Vishnubalaji, Radhakrishnan, et al.
Publicado: (2022)

Molecular Classification of Breast Cancer Utilizing Long Non-Coding RNA (lncRNA) Transcriptomes Identifies Novel Diagnostic lncRNA Panel for Triple-Negative Breast Cancer
por: Shaath, Hibah, et al.
Publicado: (2021)

Enhanced Thermal Stability, Mechanical Properties and Structural Integrity of MWCNT Filled Bamboo/Kenaf Hybrid Polymer Nanocomposites
por: Prabhudass, J. M., et al.
Publicado: (2022)

Molecular classification of triple-negative tumors
por: Prat, A, et al.
Publicado: (2011)

Current knowledge on alleviating Helicobacter pylori infections through the use of some commonly known natural products: bench to bedside
por: Murali, Malliga Raman, et al.
Publicado: (2014)

Molecular-Genetic Portrait of Breast Cancer with Triple Negative Phenotype
por: Ibragimova, Marina K., et al.
Publicado: (2021)

Molecular Classification Models for Triple Negative Breast Cancer Subtype Using Machine Learning
por: Bissanum, Rassanee, et al.
Publicado: (2021)

A Comparative Study on Morphochemical Properties and Osteogenic Cell Differentiation within Bone Graft and Coral Graft Culture Systems
por: Puvaneswary, Subramaniam, et al.
Publicado: (2013)

Classification of triple-negative breast cancers based on Immunogenomic profiling
por: He, Yin, et al.
Publicado: (2018)

Triple Negative Breast Cancer: Updates on Classification and Treatment in 2021
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

The nature of triple-negative breast cancer classification and antitumoral strategies
por: Kim, Songmi, et al.
Publicado: (2020)

Exploring specific prognostic biomarkers in triple-negative breast cancer
por: Bao, Chang, et al.
Publicado: (2019)

Immune-related biomarkers in triple-negative breast cancer
por: Zhang, Juan, et al.
Publicado: (2021)

LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
por: Lv, Mingming, et al.
Publicado: (2016)

Fate of tenogenic differentiation potential of human bone marrow stromal cells by uniaxial stretching affected by stretch-activated calcium channel agonist gadolinium
por: Nam, Hui Yin, et al.
Publicado: (2017)

Mechanical Strain-Mediated Tenogenic Differentiation of Mesenchymal Stromal Cells Is Regulated through Epithelial Sodium Channels
por: Nam, Hui Yin, et al.
Publicado: (2020)

Immune Classification and Immune Landscape Analysis of Triple-Negative Breast Cancer
por: Hu, Shaojun, et al.
Publicado: (2021)

Molecular characteristics of recurrent triple-negative breast cancer
por: TSAI, CHUNG-HSIN, et al.
Publicado: (2015)

Endocan as a prognostic biomarker of triple-negative breast cancer
por: Sagara, Atsunobu, et al.
Publicado: (2016)

Can MRI Biomarkers Predict Triple-Negative Breast Cancer?
por: Moffa, Giuliana, et al.
Publicado: (2020)

New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer
por: El Hejjioui, Brahim, et al.
Publicado: (2023)

Transcriptional alterations of protein coding and noncoding RNAs in triple negative breast cancer in response to DNA methyltransferases inhibition
por: Elango, Ramesh, et al.
Publicado: (2021)

Triple-Negative Breast Cancer Analysis Based on Metabolic Gene Classification and Immunotherapy
por: Zhou, Yu, et al.
Publicado: (2022)

Molecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast Carcinomas
por: Kuo, Wen-Hung, et al.
Publicado: (2012)

A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers
por: Liu, Man, et al.
Publicado: (2017)

Biocompatibility and Toxicity of Poly(vinyl alcohol)/N,O-Carboxymethyl Chitosan Scaffold
por: Kamarul, Tunku, et al.
Publicado: (2014)

Potential Use of 3D CORAGRAF-Loaded PDGF-BB in PLGA Microsphere Seeded Mesenchymal Stromal Cells in Enhancing the Repair of Calvaria Critical-Size Bone Defect in Rat Model
por: Mohan, Saktiswaren, et al.
Publicado: (2022)

Triple Negative Breast Cancer – An Overview
por: Aysola, Kartik, et al.
Publicado: (2013)

RUNX2: a prognostic biomarker for triple-negative breast cancer?
Publicado: (2014)

Current advances in biomarkers for targeted therapy in triple-negative breast cancer
por: Fleisher, Brett, et al.
Publicado: (2016)

Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives
por: Cocco, Stefania, et al.
Publicado: (2020)

Development of an immune-related prognostic biomarker for triple-negative breast cancer
por: Zhang, Yan, et al.
Publicado: (2022)

Triple-negative breast cancer: promising prognostic biomarkers currently in development
por: Sukumar, Jasmine, et al.
Publicado: (2021)

Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy
por: Peddi, Parvin F., et al.
Publicado: (2012)

Molecular heterogeneity in adjacent cells in triple-negative breast cancer
por: Huebschman, Michael L, et al.
Publicado: (2015)

Triple-negative breast cancer molecular subtyping and treatment progress
por: Yin, Li, et al.
Publicado: (2020)

Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer
por: Nakhjavani, Maryam, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sv429ede3nkfuo01lu6kvvksoq